PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

8 Tipping Points: Pharm Exec's 2019 Industry Forecast

Regulatory Reform in China: A Q&A with Dr. Lingshi Tan

ICER: Going Global

Advertisement
Global
China: A Change in Attitude
How innovation growth has upped the pressure on China to compete globally, forcing upgrades in regulatory, quality, and standards
/Read more/
Global
New Roads to China
How the nation's rapidly changing regulatory climate is creating a new landscape for pharmaceutical service providers
/Read more/
Global
Mixed Outlook for China Life Sciences
Momentum and uncertainty shape the sector's economic picture. Michelle Maskaly reports
/Read more/
Global
CFIUS Reform's Impact on Biopharma
What the new rules mean for Chinese-related investments and acquisitions in the US. By Peter Young
/Read more/
The Pharm Exec Podcast: Industry Trends 2019
The Pharm Exec editors discuss what lies ahead for the biopharma industry in the coming months
/Read more/
Calendar
/ February 20–21: Oncology Market Access Strategy Summit /
San Francisco, CA
/ February 26–27: 12th Hub and SPP Model Optimization /
Philadelphia, PA
/ March 4–6: 20th Annual Patient Assistance and Access Programs – PAP 2019 /
Baltimore, MD
/ March 12–13: Pharmaceutical Compliance Congress Asia /
Shanghai, China
/ March 12–13: e–Rx and EHR 2019 /
Philadelphia, PA
/ March 12–14: 17th Annual eyeforpharma Barcelona /
Barcelona, Spain
/ March 18– 21: DCAT Week '19 /
New York City, NY
/ March 20–22: 15th Life Sciences Accounting and Reporting Congress /
Philadelphia, PA
/ March 20–March 21: Partnering with IDNs Biopharma Strategy Summit West /
Scottsdale, AZ
/ March 27–28: 12th Annual Expanded Access Programs /
Philadelphia, PA
/ June 12–13: Rare Disease Innovation and Partnering Summit /
Boston, MA
Industry update
// Following the completion of the Shire acquisition, Takeda UK & Ireland has announced Jon Neal as General Manager of the combined company. // Immunocore (Abingdon, UK) named Bahija Jallal as its new Chief Executive and Director of the Board. // Dr. Reddy's Laboratories Ltd (Hyderabad, India and Princeton, NJ) announced the appointment of Marc Kikuchi as Chief Executive Officer. // AC Immune (Lausanne, Switzerland) appointed Dr. Marie Kosco-Vilbois, as Chief Scientific Officer.
 
update my profile / advertise with us / print subscribe / digital subscribe / visit pharmexec.com